Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Bio-pharma market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bio-pharmamarket, defines the market attractiveness level of Bio-pharma market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bio-pharma industry, describes the types of Bio-pharma market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bio-pharma market and the development prospects and opportunities of Bio-pharma industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bio-pharma market in Chapter 13.
By Player:
Biogen Idec
Sanofi, Amgen
Bristol-Myers Squibb Company
Eli Lilly and Company
Abbott Laboratories
AbbVie
Merck & Co, Inc
Novartis AG GlaxoSmithKline Plc
Johnson & Johnson Services
F Hoffmann-La Roche AG
AstraZeneca PLC
Bayer AG
Pfizer
By Type:
Monoclonal Antibodies
Recombinant Proteins
Granulocyte-Colony Stimulating Factor (G-CSF)
Interferons
Recombinant Human Insulin
Erythropoietin
Vaccines
Growth Hormones
Purified Proteins
Others
By End-User:
Metabolic Disorders
Oncology
Neurological Disorders
Cardiovascular Diseases
Inflammatory and Infectious Diseases
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bio-pharma Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bio-pharma Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bio-pharma Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bio-pharma Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bio-pharma Market Analysis and Outlook to 2022
-
7.1 Global Bio-pharma Consumption (2017-2022)
-
7.2 United States Bio-pharma Consumption (2017-2022)
-
7.3 Europe Bio-pharma Consumption (2017-2022)
-
7.4 China Bio-pharma Consumption (2017-2022)
-
7.5 Japan Bio-pharma Consumption (2017-2022)
-
7.6 India Bio-pharma Consumption (2017-2022)
-
7.7 South Korea Bio-pharma Consumption (2017-2022)
8 Region and Country-wise Bio-pharma Market Analysis and Outlook to 2028
-
8.1 Global Bio-pharma Consumption Forecast (2022-2028)
-
8.2 United States Bio-pharma Consumption Forecast (2022-2028)
-
8.3 Europe Bio-pharma Consumption Forecast (2022-2028)
-
8.4 China Bio-pharma Consumption Forecast (2022-2028)
-
8.5 Japan Bio-pharma Consumption Forecast (2022-2028)
-
8.6 India Bio-pharma Consumption Forecast (2022-2028)
-
8.7 South Korea Bio-pharma Consumption Forecast (2022-2028)
9 Global Bio-pharma Market Outlook by Types and Applications to 2022
-
9.1 Global Bio-pharma Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Recombinant Proteins Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Interferons Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Recombinant Human Insulin Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Erythropoietin Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Growth Hormones Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Purified Proteins Consumption and Growth Rate (2017-2022)
-
9.1.10 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Bio-pharma Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Inflammatory and Infectious Diseases Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Global Bio-pharma Market Outlook by Types and Applications to 2028
-
10.1 Global Bio-pharma Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Recombinant Proteins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Interferons Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Recombinant Human Insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.8 Global Growth Hormones Consumption Forecast and Growth Rate (2022-2028)
-
10.1.9 Global Purified Proteins Consumption Forecast and Growth Rate (2022-2028)
-
10.1.10 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bio-pharma Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Inflammatory and Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Bio-pharma Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bio-pharma Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bio-pharma Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bio-pharma Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bio-pharma Market Competitive Analysis
-
14.1 Biogen Idec
-
14.1.1 Biogen Idec Company Details
-
14.1.2 Biogen Idec Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Biogen Idec Bio-pharma Product and Service
-
14.2 Sanofi, Amgen
-
14.2.1 Sanofi, Amgen Company Details
-
14.2.2 Sanofi, Amgen Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi, Amgen Bio-pharma Product and Service
-
14.3 Bristol-Myers Squibb Company
-
14.3.1 Bristol-Myers Squibb Company Company Details
-
14.3.2 Bristol-Myers Squibb Company Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Company Bio-pharma Product and Service
-
14.4 Eli Lilly and Company
-
14.4.1 Eli Lilly and Company Company Details
-
14.4.2 Eli Lilly and Company Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly and Company Bio-pharma Product and Service
-
14.5 Abbott Laboratories
-
14.5.1 Abbott Laboratories Company Details
-
14.5.2 Abbott Laboratories Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Abbott Laboratories Bio-pharma Product and Service
-
14.6 AbbVie
-
14.6.1 AbbVie Company Details
-
14.6.2 AbbVie Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AbbVie Bio-pharma Product and Service
-
14.7 Merck & Co, Inc
-
14.7.1 Merck & Co, Inc Company Details
-
14.7.2 Merck & Co, Inc Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merck & Co, Inc Bio-pharma Product and Service
-
14.8 Novartis AG GlaxoSmithKline Plc
-
14.8.1 Novartis AG GlaxoSmithKline Plc Company Details
-
14.8.2 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Product and Service
-
14.9 Johnson & Johnson Services
-
14.9.1 Johnson & Johnson Services Company Details
-
14.9.2 Johnson & Johnson Services Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Johnson & Johnson Services Bio-pharma Product and Service
-
14.10 F Hoffmann-La Roche AG
-
14.10.1 F Hoffmann-La Roche AG Company Details
-
14.10.2 F Hoffmann-La Roche AG Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 F Hoffmann-La Roche AG Bio-pharma Product and Service
-
14.11 AstraZeneca PLC
-
14.11.1 AstraZeneca PLC Company Details
-
14.11.2 AstraZeneca PLC Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 AstraZeneca PLC Bio-pharma Product and Service
-
14.12 Bayer AG
-
14.12.1 Bayer AG Company Details
-
14.12.2 Bayer AG Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Bayer AG Bio-pharma Product and Service
-
14.13 Pfizer
-
14.13.1 Pfizer Company Details
-
14.13.2 Pfizer Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Pfizer Bio-pharma Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bio-pharma
-
Figure Bio-pharma Picture
-
Table Global Bio-pharma Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bio-pharma Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bio-pharma Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bio-pharma Consumption by Country (2017-2022)
-
Figure United States Bio-pharma Consumption and Growth Rate (2017-2022)
-
Table Europe Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure China Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Japan Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure India Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bio-pharma Consumption and Growth Rate (2017-2022)
-
Figure Global Bio-pharma Consumption Forecast by Country (2022-2028)
-
Figure United States Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bio-pharma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Proteins Consumption and Growth Rate (2017-2022)
-
Figure Global Granulocyte-Colony Stimulating Factor (G-CSF) Consumption and Growth Rate (2017-2022)
-
Figure Global Interferons Consumption and Growth Rate (2017-2022)
-
Figure Global Recombinant Human Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Erythropoietin Consumption and Growth Rate (2017-2022)
-
Figure Global Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Growth Hormones Consumption and Growth Rate (2017-2022)
-
Figure Global Purified Proteins Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Metabolic Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Neurological Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammatory and Infectious Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recombinant Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Granulocyte-Colony Stimulating Factor (G-CSF) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Interferons Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Recombinant Human Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Erythropoietin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Growth Hormones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Purified Proteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Metabolic Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neurological Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inflammatory and Infectious Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bio-pharma Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bio-pharma Export by Region (Top 5 Countries) (2017-2028)
-
Table Biogen Idec (Foundation Year, Company Profile and etc.)
-
Table Biogen Idec Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Idec Bio-pharma Product and Service
-
Table Sanofi, Amgen (Foundation Year, Company Profile and etc.)
-
Table Sanofi, Amgen Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi, Amgen Bio-pharma Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Bio-pharma Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Bio-pharma Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Bio-pharma Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Bio-pharma Product and Service
-
Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co, Inc Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc Bio-pharma Product and Service
-
Table Novartis AG GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Product and Service
-
Table Johnson & Johnson Services (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Services Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Services Bio-pharma Product and Service
-
Table F Hoffmann-La Roche AG (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche AG Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche AG Bio-pharma Product and Service
-
Table AstraZeneca PLC (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca PLC Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca PLC Bio-pharma Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Bio-pharma Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Bio-pharma Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Bio-pharma Product and Service
-
